Catheter Precision Inc’s recent filing unveils that its Director COLOMBATTO MARTIN J unloaded Company’s shares for reported $1.0 on Jan 29 ’25. In the deal valued at $0.40 per share,3 shares were sold. As a result of this transaction, COLOMBATTO MARTIN J now holds 0 shares worth roughly $0.0.
Piper Jaffray downgraded its Catheter Precision Inc [VTAK] rating to a Neutral from a an Overweight in a research note published on August 13, 2019; the price target was decreased to $1.50 from $9. A number of analysts have revised their coverage, including Maxim Group’s analysts, who began to cover the stock in early November with a ‘”a Buy”‘ rating.
Price Performance Review of VTAK
On Monday, Catheter Precision Inc [AMEX:VTAK] saw its stock jump 2.76% to $0.29. Over the last five days, the stock has gained 6.14%. Catheter Precision Inc shares have fallen nearly -34.83% since the year began. Nevertheless, the stocks have fallen -94.91% over the past one year. While a 52-week high of $8.40 was reached on 01/06/25, a 52-week low of $0.24 was recorded on 04/07/25. SMA at 50 days reached $0.3288, while 200 days put it at $0.5737.
Levels Of Support And Resistance For VTAK Stock
The 24-hour chart illustrates a support level at 0.2799, which if violated will result in even more drops to 0.2660. On the upside, there is a resistance level at 0.3089. A further resistance level may holdings at 0.3240. The Relative Strength Index (RSI) on the 14-day chart is 47.74, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0025, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 73.92%. Stochastics %K at 20.44% indicates the stock is a holding.
